Celldex Therapeutics (CLDX) Prepaid Assets (2010 - 2026)

Celldex Therapeutics' Prepaid Assets history runs 17 years deep, the most recent figure standing at $7.5 million for Q1 2026.

• In Q1 2026, Prepaid Assets fell 61.17% year-over-year to $7.5 million; the TTM figure through Mar 2026 stood at $7.5 million (down 61.17% YoY), while the FY2025 annual figure was $14.1 million, down 33.53% from the prior year.
• Prepaid Assets for Q1 2026 stood at $7.5 million, down from $14.1 million in the prior quarter.
• The five-year high for Prepaid Assets was $22.0 million in Q3 2024, with the low at $5.5 million in Q4 2023.
• The 5-year median for Prepaid Assets is $11.1 million (2022), against an average of $13.1 million.
• The sharpest annual moves came in 2022 and 2026: Prepaid Assets jumped 412.78% in 2022, then slumped 61.17% in 2026.
• Celldex Therapeutics' Prepaid Assets stood at $12.4 million in 2022, then sank by 55.89% to $5.5 million in 2023, then jumped by 287.38% to $21.2 million in 2024, then slumped by 33.53% to $14.1 million in 2025, then plunged by 46.48% to $7.5 million in 2026.
• Business Quant data shows CLDX's Prepaid Assets at $7.5 million in Q1 2026, $14.1 million in Q4 2025, and $21.0 million in Q3 2025.